Weh-Weh Pain Reliever Gel

Description

The product is identified by the SPL Code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the topical treatment of localized pain. It is recommended to apply a generous amount of gel directly to the affected area and to massage it into the skin until thoroughly absorbed.

Limitations of Use: The safety and efficacy of this drug have not been established in populations outside of those experiencing localized pain.

Dosage and Administration

The external topical analgesic should be applied as a massage gel to the affected area. The recommended dosing frequency is no more than four times daily. It is important to ensure that the gel is applied evenly and gently massaged into the skin for optimal absorption and effectiveness. Healthcare professionals should advise patients to avoid exceeding the maximum frequency to minimize the risk of adverse effects.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: redness, irritation, worsening of conditions, or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, medical advice should be sought.

Warnings and Precautions

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Healthcare professionals should instruct patients to discontinue use and consult a physician if any of the following occur: the presence of redness, the development of irritation, worsening of conditions, or if symptoms persist for more than 7 days. Additionally, if symptoms initially resolve and then recur within a few days, medical advice should be sought.

Side Effects

In clinical use, patients may experience a range of adverse reactions. Serious adverse reactions necessitate immediate medical attention. It is crucial to keep the product out of reach of children; if the product is swallowed, patients should seek medical help or contact a Poison Control Center without delay.

Common adverse reactions may include redness and irritation. Patients are advised to discontinue use and consult a healthcare professional if they observe redness, develop irritation, or if their condition worsens or symptoms persist for more than seven days. Additionally, if symptoms resolve and then recur within a few days, it is recommended that patients seek medical advice.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Weh-Weh Pain Reliever Gel (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event that the product is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of Weh-Weh Pain Relief Gel in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the general considerations for medication use in older adults.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider prior to use. While potential risks to the fetus are not specified, caution is advised. There are no specific dosage modifications for pregnant individuals. It is recommended that women of childbearing potential discuss the use of this product with their healthcare provider to ensure informed decision-making regarding potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of Weh-Weh Pain Reliever Gel in lactating mothers. Additionally, there is no information available about the potential for excretion of the product in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Should ingestion occur, immediate medical assistance is required. Healthcare professionals are advised to contact a Poison Control Center without delay to ensure appropriate management and intervention.

Prompt action is crucial in mitigating potential adverse effects associated with overdosage. The symptoms may vary depending on the specific product involved; therefore, a thorough assessment and appropriate treatment plan should be initiated based on the clinical presentation and guidance from poison control experts.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to discontinue use of the product and consult a physician if they experience any redness, irritation, or if their condition worsens. Patients should be informed that if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, they should seek medical advice. It is important for patients to understand the significance of these signs and symptoms in relation to their treatment.

Storage and Handling

This product should be protected from excessive heat and direct sunlight to maintain its integrity and efficacy. It is essential to store the product in a cool, dry place, away from sources of heat and light. Proper handling and storage conditions are crucial to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Weh-Weh Pain Reliever Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)